Insulin therapy

Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 unit per kg, or as replacement, starting at 0.6 to 1.0 unit per kg. When using replacement therapy, 50 percent of the total daily insulin dose is given as basal, and 50 percent as bolus, divided up before breakfast, lunch, and dinner. Augmentation therapy can include basal or bolus insulin. Replacement therapy includes basal-bolus insulin and correction or premixed insulin.

    Related Conference of Insulin therapy

    November 21-22, 2018

    14th World Congress on Endocrinology & Diabetes

    Paris, France
    November 26-27, 2018

    26th International Diabetes and Healthcare Conference

    Helsinki, Finland
    November 26-27, 2018

    13th European Diabetes and Endocrinology Congress

    Dublin, Ireland
    February 27-28, 2019

    Asia Pacific Diabetes and Endocrinology Congress

    Radisson Hotel Narita, Tokyo, Japan

    April 17-18, 2019

    21st Asia Pacific Diabetes Conference

    Osaka,Japan
    May 17-18, 2019

    2nd Global Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome

    Holiday Inn Singapore Atrium | Singapore
    May 30-31, 2019

    2nd Global Meeting on Diabetes and Endocrinology

    Istanbul, Turkey
    June 10-11, 2019

    28th European Diabetes Congress

    | Edinburgh, Scotland
    July 24-25, 2019

    29th World Diabetes & Heart Congress

    Melbourne, Australia
    July 29-30, 2019

    12th International Conference on Diabetes & Metabolism

    Chicago | Illinois| USA
    Oct 03-04, 2019

    Euro Diabetes Congress & Expo

    | Paris, France

    Insulin therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in